|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 107.5 USD | +0.87% |
|
+1.61% | -11.70% |
| 16/07 | Truist Lowers Price Target on Zimmer Biomet Holdings to $117 From $130, Keeps Hold Rating | MT |
| 16/07 | Osteopore Taps Zimmer Biomet as Exclusive Distributor in EMEA, APAC; Shares Jump 30% | MT |
Jan 5 (Reuters) - Zimmer Biomet Holdings Inc:
* ZIMMER BIOMET TO ACQUIRE EMBODY, INC.
* ZIMMER BIOMET HOLDINGS INC - PROPOSED DEAL FOR FOR $155 MILLION AT CLOSING AND UP TO AN ADDITIONAL $120 MILLION
* ZIMMER BIOMET - DEAL EXPECTED TO BE ACCRETIVE TO OVERALL REVENUE GROWTH AND SLIGHTLY DILUTIVE TO ADJUSTED EARNINGS PER SHARE IN 2023 Source text for Eikon: Further company coverage:
| 1st Jan change | Capi. | |
|---|---|---|
| -11.70% | 2.21TCr | |
| -6.68% | 18TCr | |
| -5.20% | 10TCr | |
| -5.38% | 6.67TCr | |
| +18.16% | 4.48TCr | |
| -6.47% | 4.62TCr | |
| +9.74% | 4.44TCr | |
| +14.01% | 2.95TCr | |
| +22.31% | 2.58TCr | |
| -6.53% | 2.4TCr |
ZIMMER BIOMET HOLDINGS, INC. 
